Ruti Aga's Six-Year Ban Came From a Forged Prescription, Not a Steroid

A half marathon was run in China in March. Ruti Aga won it. Not one split, not one finishing time, not one line of field strength from that race survives in print. What survives is the Athletics Integrity Unit's statement, dated 10 September: a six-year ban. On the track I build a story out of a 100m split table. Here the splits have been replaced by dates — the March race, the provisional suspension running from 10 September, and in between, two years plus four years, added up plainly. A winner's mark was lost to history because the sample was taken the same day.

The statement gives neither the year nor the name of the race; the sequence suggests the current year. I will not put an inference where a fact belongs.

Aga is 32. She won the 2026 Tokyo Marathon, finished second in Berlin in 2026, and has three second-place finishes at World Marathon Majors. My notebook has Tokyo at 2:20:40 and Berlin at 2:18:34 — a generation in which 2:18 was not a guaranteed podium. That is the line most under-quoted in this case: a six-year ban was not handed to a marginal runner. It was handed to a major champion.

Per the AIU, the sample taken after the March race showed methylprednisolone. Aga cited a knee injury and produced treatment paperwork. The paperwork collapsed under verification: the doctor who wrote the prescription was a family member with no medical registration; the clinic named on the prescription did not exist; and when questioned, that person said he had used an old prescription pad from a former workplace, a pad the clinic explicitly disowned.

These are three independent verification failures, and they — not the drug — are the reason this sanction is six years long.

The arithmetic is straightforward: two years for the presence of methylprednisolone, four for tampering. Six total. The two-year figure tells us the panel did not find proven intent — otherwise a specified-substance case usually attracts some mitigation. The four-year figure tells us the panel held the document manipulation fully culpable. Backdating to 10 September is not a discount; provisional suspension time counts against the ban, so the athlete gains nothing in real terms.

Here is the point that troubles me most, because it is the point missing from the coverage. Methylprednisolone is a glucocorticoid under class S9 of the WADA Prohibited List, not an anabolic steroid under S1, and S9 substances are prohibited in-competition only, by injection, oral or rectal routes. A therapeutic knee injection given out-of-competition is entirely lawful; it becomes a violation only if residues are present in the in-competition sample. And the substance has no proven performance benefit in endurance sport; it works on pain and inflammation.

This was never a performance-enhancing drug case. It was a timing-and-route case. An intra-articular injection for knee synovitis is ordinary sports medicine in distance running. Had real medical records existed, a legitimate defence existed: hold or apply for a TUE, or observe the WADA route-specific washout before racing. At minimum, a no-significant-fault argument was available. She closed that route herself with a forged prescription.

This is where structural sympathy has to be separated from absolution. The medical network serving Ethiopian and Kenyan road-racing squads is often not a credentialed team physician but a set of informal contacts. Racing injured is an economic decision: appearance fees and prize money at Asian label races are these athletes' real income, because there is no league contract underneath. The knee is bad, the race is three weeks away, the fee is large, and the cheapest fix is a corticosteroid. That structure explains where the error came from. It does not excuse it. Forging a prescription was a choice, and choices are accounted for. Keep the asterisk visible: this is a sanction on established facts, not on suspicion.

And then the question Indian sports journalism asks least: how much space did this get? I counted. Across the outlets that run three features on every frame of a Neeraj Chopra throw in an Olympic year, there was almost nothing that week on a major champion's six-year ban. That is not a moral complaint; it is a tally. And the tally says athletics coverage still runs on the quadrennial rhythm: long silence, then a few weeks of noise.

The most counter-intuitive fact in this case is that four of the six years came from paperwork, not from a drug. The enforcement frontier has shifted from detection to document verification, and that is the fastest-growing category in East African road-running cases. Being caught used to be the offence. Now explaining it is also an exam, and failing that exam often costs more than the original violation.

Commercially, Aga's career ended not on 10 September but in March, with that sample. Six years at 32 means a return at roughly 38 — and inside the depth of Ethiopian women's marathoning, a 38-year-old returning with a doping record is not selectable. Her 2026 Tokyo title should stand, because the violation is anchored to a later race and the statement does not mention annulment of earlier results; the March result and its prize money are very likely void, though the AIU does not spell that out.

The question now is not whether Aga is culpable — that is settled. It is where the next case comes from. The informal networks that produced this prescription serve dozens of athletes in the same training clusters. The AIU has an investigative apparatus for road races; the athletes have no equivalent apparatus telling them when a knee injection is permissible and how to keep the paper. Until that education arrives, the bans will keep coming and the stories will keep collapsing into one line — steroid case — which may be the biggest error in this one.

Three mispronounced names taught me that a microphone is a responsibility before it is a voice. Misnaming a drug class belongs to the same family of error. It is not a pronunciation slip; it is a chemistry slip. And if a fan remembers this as a steroid case, then the next time an athlete stands behind genuine medical records, nobody will be able to tell the difference.